Korsana Biosciences, Inc. (KRSA)
31.04
-0.13
(-0.42%)
USD |
NASDAQ |
Nov 10, 16:00
31.04
0.00 (0.00%)
After-Hours: 20:00
Korsana Biosciences Cash from Operations (Annual) : -3.314M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -3.314M |
| December 31, 2024 | -4.333M |
| December 31, 2023 | -21.24M |
| December 31, 2022 | -40.61M |
| December 31, 2021 | -36.52M |
| Date | Value |
|---|---|
| December 31, 2020 | -72.49M |
| December 31, 2019 | -102.22M |
| December 31, 2018 | -97.50M |
| December 31, 2017 | -81.22M |
| December 31, 2016 | -49.87M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Q32 Bio, Inc. | -33.54M |
| IRulya Therapeutics, Inc. | -41.42M |
| Climb Bio, Inc. | -54.36M |
| PepGen Inc. | -81.64M |
| Bridgebio Oncology Therapeutics, Inc. | -113.89M |